Evidence map›Paper›PMID 39163129›Full record

ArticleJCI insight2024

Dysregulated immunologic landscape of the early host response in melioidosis.

Patpong Rongkard, Lu Xia, Barbara Kronsteiner, Thatcha Yimthin, Rungnapa Phunpang, Adul Dulsuk, Viriya Hantrakun, Gumphol Wongsuvan, Parinya Chamnan, Lara Lovelace-Macon and 9 more

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Reply to Yu et al.The Journal of infectious diseases · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Patpong RongkardNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Lu XiaDepartment of Statistics and Probability, Michigan State University, East Lansing, USA.
Barbara KronsteinerNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Thatcha YimthinDepartment of Microbiology and Immunology, Mahidol University, Bangkok, Thailand.
Rungnapa PhunpangMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Adul DulsukMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Viriya HantrakunMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Gumphol WongsuvanMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Parinya ChamnanSunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.
Lara Lovelace-MaconDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, USA.
Emanuele MarchiPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Nicholas Pj DayNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Ali ShojaieDepartment of Biostatistics, University of Washington, Seattle, USA.
Direk LimmathurotsakulMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Narisara ChantratitaMahidol-Oxford Tropical Medicine Research Unit, Salaya, Thailand.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Susanna J DunachieNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
T Eoin WestDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, USA.
Sina A GharibDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, USA.

Funding

Integrated Multi-omics of MelioidosisR01AI137111 · NIAID · UNIVERSITY OF WASHINGTON · PI GHARIB, SINA A, WEST, TIMOTHY EOIN · 2018 to 2021
$3.2M
Regulation of host inflammatory responses and outcome in melioidosis by TLR5R01HL113382 · NHLBI · UNIVERSITY OF WASHINGTON · PI WEST, TIMOTHY EOIN · 2012 to 2016
$2.6M
Determinants of Outcome and Recurrent Infections in MelioidosisU01AI115520 · NIAID · MAHIDOL UNIVERSITY · PI CHANTRATITA, NARISARA, WEST, TIMOTHY EOIN · 2015 to 2019
$2.0M
NHLBI NIH HHS R01 HL113382NIAID NIH HHS R01 AI137111NIAID NIH HHS U01 AI115520UK NIH & Care Research NIHR300791Wellcome TrustWellcome Trust 100174/Z/12/ZWellcome Trust 222426/Z/21/Z
6 · The paper itself

Abstract

Melioidosis, a neglected tropical infection caused by Burkholderia pseudomallei, commonly presents as pneumonia or sepsis with mortality rates up to 50% despite appropriate treatment. A better understanding of the early host immune response to melioidosis may lead to new therapeutic interventions and prognostication strategies to reduce disease burden. Whole blood transcriptomic signatures in 164 patients with melioidosis and in 70 patients with other infections hospitalized in northeastern Thailand enrolled within 24 hours following hospital admission were studied. Key findings were validated in an independent melioidosis cohort. Melioidosis was characterized by upregulation of interferon (IFN) signaling responses compared with other infections. Mortality in melioidosis was associated with excessive inflammation, enrichment of type 2 immune responses, and a dramatic decrease in T cell-mediated immunity compared with survivors. We identified and independently confirmed a 5-gene predictive set classifying fatal melioidosis (validation cohort area under the receiver operating characteristic curve 0.83; 95% CI, 0.67-0.99). This study highlights the intricate balance between innate and adaptive immunity during fatal melioidosis and can inform future precision medicine strategies for targeted therapies and prognostication in this severe infection.

Indexed as

Burkholderia pseudomalleiMelioidosisAdaptive ImmunityAdultAgedFemaleHumansImmunity, InnateInterferonsMaleMiddle AgedThailandTranscriptomeInterferonsBacterial infectionsExpression profilingImmunologyInfectious disease

Identifiers

PMID39163129
PMCPMC11457863

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.